Rein Therapeutics, Inc. (RNTX) Net Income by Year
Rein Therapeutics, Inc. reported a net loss of $49.9M in fiscal year 2025. This represents an increase of 20.7% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Rein Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RNTX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
RNTX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Rein Therapeutics, Inc. financials
Frequently Asked Questions
What was Rein Therapeutics, Inc.'s net income in fiscal year 2025?
Rein Therapeutics, Inc. reported a net loss of $49.9M in fiscal year 2025.
How fast is Rein Therapeutics, Inc.'s net income growing?
Rein Therapeutics, Inc. (RNTX) net income rose by 20.7% year over year, from -$62.9M to -$49.9M in fiscal year 2025.
How has Rein Therapeutics, Inc.'s net income changed over the years?
Across the 11 fiscal years this page covers, Rein Therapeutics, Inc. (RNTX) net income went from -$12.9M in fiscal year 2015 to -$49.9M in fiscal year 2025.
What was Rein Therapeutics, Inc.'s net income in the most recent quarter?
Rein Therapeutics, Inc. (RNTX) reported -$6.4M in net income in Q2 2026. This represents an increase of 6.6% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Rein Therapeutics, Inc. (RNTX) reported on that line in every period on record.